External validation of the Fetal Medicine Foundation algorithm for the prediction of preeclampsia in a Brazilian population
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Pregnancy Hypertension
- Vol. 17, 64-68
Abstract
No abstract availableKeywords
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/110.578/2012)
This publication has 25 references indexed in Scilit:
- A Competing Risks Model in Early Screening for PreeclampsiaFetal Diagnosis and Therapy, 2012
- Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeksPrenatal Diagnosis, 2011
- Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous womenAmerican Journal of Obstetrics and Gynecology, 2010
- Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early PregnancyObstetrics & Gynecology, 2010
- Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approachJournal of Human Hypertension, 2009
- Mean Arterial Pressure at 11 +0 to 13 +6 Weeks in the Prediction of PreeclampsiaHypertension, 2008
- Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysisCanadian Medical Association Journal, 2008
- Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2007
- External validation is necessary in prediction research:Journal of Clinical Epidemiology, 2003
- THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)Hypertension in Pregnancy, 2001